Janney Montgomery Scott Starts Jazz Pharmaceuticals (JAZZ) at Neutral
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $245.57 --0%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 11 | New: 21
Join SI Premium – FREE
Janney Montgomery Scott initiated coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with a Neutral rating.
For an analyst ratings summary and ratings history on Jazz Pharmaceuticals click here. For more ratings news on Jazz Pharmaceuticals click here.
Shares of Jazz Pharmaceuticals closed at $129.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Starts Vishay Intertechnology (VSH) at Buy
- Morgan Stanley Starts Ithaca Energy (ITH:LN) at Equalweight
- Morgan Stanley Resumes St. James's Place Plc. (STJ:LN) (STJPF) at Equalweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
